{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T21:02:08Z","timestamp":1795035728995,"version":"4.10.2"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The role of autophagy in cancer onset and progression appears still controversial. On one hand, autophagy allows cancer cell to survive in unfavorable environmental conditions, on the other hand, once internal energy resources are exhausted, it leads to cell death. In addition, autophagy interpheres with cell cycle progression, de facto exerting a cytostatic activity. Hence, it represents an important target for anticancer therapy. For example, temozolomide (TMZ), of use for glioblastoma (GBM) treatment, appears as capable of inducing autophagy partially inhibiting cancer cell proliferation. However, GBM, a very aggressive brain tumor with poor prognosis even after surgery and radio-chemotherapy, invariably recurs and leads to patient death. Since cancer stem cells have been hypothesized to play a role in refractory\/relapsing cancers, in the present work we investigated if autophagy could represent a constitutive cytoprotection mechanism for glioblastoma stem-like cells (GSCs) and if the modulation of autophagic process could affect GBM growth and survival. Thus, in the present study we first evaluated the relevance of autophagy in GBM tumor specimens, then its occurrence in GSCs and, finally, if modulation of autophagy could influence GSC response to TMZ. Our results suggested that, in vitro, the impairing autophagic process with quinacrine, a compound able to cross the blood-brain barrier, increased GSC susceptibility to TMZ. Death of GSCs was apparently due to the iron dependent form of programmed cell death characterized by the accumulation of lipid peroxides called ferroptosis. These results underscore the relevance of the modulation of autophagy in the GSC survival and death and suggest that triggering of ferroptosis in GSCs could represent a novel and important target for the management of glioblastoma.<\/jats:p>","DOI":"10.1038\/s41419-018-0864-7","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T11:22:40Z","timestamp":1533554560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":237,"title":["Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis"],"prefix":"10.1038","volume":"9","author":[{"given":"Mariachiara","family":"Buccarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Pacioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"De Pascalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quintino Giorgio","family":"D\u2019Alessandris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ascione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1223-7000","authenticated-orcid":false,"given":"Walter","family":"Malorni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1739-4758","authenticated-orcid":false,"given":"Luigi Maria","family":"Larocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pallini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Ricci-Vitiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Matarrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"key":"864_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom, Q. T. et al. The epidemiology of glioma in adults: a \u201cstate of the science\u201d. Neuro. Oncol. 16, 896\u2013913 (2014).","journal-title":"Neuro. Oncol."},{"key":"864_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/nrclinonc.2012.204","volume":"10","author":"S Tanaka","year":"2013","unstructured":"Tanaka, S., Louis, D. N., Curry, W. T., Batchelor, T. T. & Dietrich, J. Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat. Rev. Clin. Oncol. 10, 14\u201326 (2013).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"864_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New Engl. J. Med. 352, 987\u2013996 (2005).","journal-title":"New Engl. J. Med."},{"key":"864_CR4","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396\u2013401 (2004).","journal-title":"Nature"},{"key":"864_CR5","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1158\/0008-5472.CAN-04-1364","volume":"64","author":"R Galli","year":"2004","unstructured":"Galli, R. et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64, 7011\u20137021 (2004).","journal-title":"Cancer Res."},{"key":"864_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/PPO.0b013e3182452e0d","volume":"18","author":"EK Nduom","year":"2012","unstructured":"Nduom, E. K., Hadjipanayis, C. G. & Van Meir, E. G. Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment. Cancer J. 18, 100\u2013106 (2012).","journal-title":"Cancer J."},{"key":"864_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.327","volume":"8","author":"A Pagotto","year":"2017","unstructured":"Pagotto, A. et al. Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells. Cell Death Dis. 8, e2943 (2017).","journal-title":"Cell Death Dis."},{"key":"864_CR8","first-page":"2103","volume":"63","author":"T Kanzawa","year":"2003","unstructured":"Kanzawa, T., Kondo, Y., Ito, H., Kondo, S. & Germano, I. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res. 63, 2103\u20132108 (2003).","journal-title":"Cancer Res."},{"key":"864_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/sj.cdd.4401359","volume":"11","author":"T Kanzawa","year":"2004","unstructured":"Kanzawa, T. et al. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 11, 448\u2013457 (2004).","journal-title":"Cell Death Differ."},{"key":"864_CR10","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/sj.cdd.4402030","volume":"14","author":"M Katayama","year":"2007","unstructured":"Katayama, M., Kawaguchi, T., Berger, M. S. & Pieper, R. O. DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ. 14, 548\u2013558 (2007).","journal-title":"Cell Death Differ."},{"key":"864_CR11","first-page":"829","volume":"32","author":"A Bilir","year":"2008","unstructured":"Bilir, A. et al. Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma. Int. J. Oncol. 32, 829\u2013839 (2008).","journal-title":"Int. J. Oncol."},{"key":"864_CR12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4161\/auto.5.4.8164","volume":"5","author":"T Shingu","year":"2009","unstructured":"Shingu, T. et al. Stage-specific effect of inhibition of autophagy on chemotherapy-induced cytotoxicity. Autophagy 5, 537\u2013539 (2009).","journal-title":"Autophagy"},{"key":"864_CR13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/ijc.24030","volume":"124","author":"T Shingu","year":"2009","unstructured":"Shingu, T. et al. Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells. Int. J. Cancer 124, 1060\u20131071 (2009).","journal-title":"Int. J. Cancer"},{"key":"864_CR14","unstructured":"Geng, Y., Kohli, L., Klocke, B. J., & Roth, K. A. Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent. 12, 473\u2013481 (2010)."},{"key":"864_CR15","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.3171\/foc.2003.14.2.4","volume":"14","author":"E Brice\u00f1o","year":"2003","unstructured":"Brice\u00f1o, E., Reyes, S. & Sotelo, J. Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine. Neurosurg. Focus 14, e3 (2003).","journal-title":"Neurosurg. Focus"},{"key":"864_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.7326\/0003-4819-144-5-200603070-00008","volume":"144","author":"J Sotelo","year":"2006","unstructured":"Sotelo, J., Brice\u00f1o, E. & L\u00f3pez-Gonz\u00e1lez, M. A. Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 144, 337\u2013343 (2006).","journal-title":"Ann. Intern. Med."},{"key":"864_CR17","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1002\/cncr.24288","volume":"115","author":"A Munshi","year":"2009","unstructured":"Munshi, A. Chloroquine in glioblastoma-new horizons for an old drug. Cancer 115, 2380\u20132383 (2009).","journal-title":"Cancer"},{"key":"864_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.canlet.2017.02.012","volume":"393","author":"Y Lei","year":"2017","unstructured":"Lei, Y. et al. Targeting autophagy in cancer stem cells as an anticancer therapy. Cancer Lett. 393, 33\u201339 (2017).","journal-title":"Cancer Lett."},{"key":"864_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"DJ Klionsky","year":"2016","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12, 1\u2013222 (2016).","journal-title":"Autophagy"},{"key":"864_CR20","doi-asserted-by":"publisher","first-page":"e564","DOI":"10.1371\/journal.pone.0055665","volume":"8","author":"AV Knizhnik","year":"2013","unstructured":"Knizhnik, A. V. et al. Survival and death strategies in glioma cells: autophagy, senescence and apoptosis triggered by a single type of temozolomide-induced DNA damage. PLoS One 8, e564\u2013e565 (2013).","journal-title":"PLoS One"},{"key":"864_CR21","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao, S. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756\u2013760 (2006).","journal-title":"Nature"},{"key":"864_CR22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11287","volume":"488","author":"J Chen","year":"2012","unstructured":"Chen, J. et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488, 522\u2013526 (2012).","journal-title":"Nature"},{"key":"864_CR23","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/neuonc\/now304","volume":"8","author":"QG D\u2019Alessandris","year":"2017","unstructured":"D\u2019Alessandris, Q. G. et al. The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response. Neuro. Oncol. 8, 1097\u20131108 (2017).","journal-title":"Neuro. Oncol."},{"key":"864_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.canlet.2012.03.002","volume":"320","author":"XL Guo","year":"2012","unstructured":"Guo, X. L. et al. Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells. Cancer Lett. 320, 171\u2013179 (2012).","journal-title":"Cancer Lett."},{"key":"864_CR25","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.1158\/1078-0432.CCR-07-1595","volume":"13","author":"RK Amaravadi","year":"2007","unstructured":"Amaravadi, R. K. & Thompson, C. B. The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin. Cancer Res. 13, 7271\u20137279 (2007).","journal-title":"Clin. Cancer Res."},{"key":"864_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep28423","volume":"6","author":"X Chen","year":"2016","unstructured":"Chen, X. et al. Trehalose, sucrose and raffinose are novel activators of autophagy in human keratinocytes through an mTOR-independent pathway. Sci. Rep. 6, 28423 (2016).","journal-title":"Sci. Rep."},{"key":"864_CR27","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.3171\/2014.12.FOCUS14748","volume":"3","author":"EB Golden","year":"2015","unstructured":"Golden, E. B. et al. Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors. Neurosurg. Focus 3, E12 (2015).","journal-title":"Neurosurg. Focus"},{"key":"864_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-017-0012-4","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi, L. et al. Molecular mechanisms of cell death: recomandations of the Nomenclature Commitee on Cell Death 2018. Cell Death Differ. https:\/\/doi.org\/10.1038\/s41418-017-0012-4 (2018).","journal-title":"Cell Death Differ."},{"key":"864_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-017-0053-8","author":"M Luo","year":"2018","unstructured":"Luo, M. et al. miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma. Cell Death Differ. https:\/\/doi.org\/10.1038\/s41418-017-0053-8 (2018).","journal-title":"Cell Death Differ."},{"key":"864_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang, W. S. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317\u2013331 (2014).","journal-title":"Cell"},{"key":"864_CR31","doi-asserted-by":"publisher","first-page":"562","DOI":"10.4161\/auto.27901","volume":"4","author":"P Pellegrini","year":"2014","unstructured":"Pellegrini, P. et al. Acidic extracellular pH neutralizes the autophagy-inhibiting activity of chloroquine. Implications for cancer therapies. Autophagy 4, 562\u2013571 (2014).","journal-title":"Autophagy"},{"key":"864_CR32","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/cdd.2008.72","volume":"15","author":"L Ricci-Vitiani","year":"2008","unstructured":"Ricci-Vitiani, L. et al. Mesenchymal differentiation of glioblastoma stem cells. Cell Death Differ. 15, 1491\u20131498 (2008).","journal-title":"Cell Death Differ."},{"key":"864_CR33","doi-asserted-by":"publisher","first-page":"8205","DOI":"10.1158\/1078-0432.CCR-08-0644","volume":"14","author":"R Pallini","year":"2008","unstructured":"Pallini, R. et al. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin. Cancer Res. 14, 8205\u20138212 (2008).","journal-title":"Clin. Cancer Res."},{"key":"864_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","volume":"24","author":"KP Bhat","year":"2013","unstructured":"Bhat, K. P. et al. Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma. Cancer Cell. 24, 331\u2013346 (2013).","journal-title":"Cancer Cell."},{"key":"864_CR35","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1517\/14712598.7.8.1129","volume":"7","author":"SG Piccirillo","year":"2007","unstructured":"Piccirillo, S. G. & Vescovi, A. L. Brain tumour stem cells: possibilities of new therapeutic strategies. Expert. Opin. Biol. Ther. 7, 1129\u20131135 (2007).","journal-title":"Expert. Opin. Biol. Ther."},{"key":"864_CR36","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/embor.2011.39","volume":"5","author":"EM Galan-Moya","year":"2011","unstructured":"Galan-Moya, E. M. et al. Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway. EMBO Rep. 5, 470\u2013476 (2011).","journal-title":"EMBO Rep."},{"key":"864_CR37","doi-asserted-by":"crossref","first-page":"20016","DOI":"10.18632\/oncotarget.7910","volume":"15","author":"L Jennewein","year":"2016","unstructured":"Jennewein, L. et al. Diagnostic and clinical relevance of the autophago-lysosomal network in human gliomas. Oncotarget 15, 20016\u201320032 (2016).","journal-title":"Oncotarget"},{"key":"864_CR38","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-11-0047","volume":"10","author":"ZJ Yang","year":"2011","unstructured":"Yang, Z. J., Chee, C. E., Huang & Sinicrope, F. A. The role of autophagy in cancer: therapeutic implications. Mol. Cancer Ther. 10, 1533\u20131541 (2011).","journal-title":"Mol. Cancer Ther."},{"key":"864_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-016-0303-5","volume":"35","author":"Y Yuanliang","year":"2016","unstructured":"Yuanliang, Y. et al. Targeting autophagy to sensitive glioma to temozolomide treatment. J. Exp. Clin. Cancer Res. 35, 23 (2016).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"864_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1158\/1535-7163.MCT-10-0688","volume":"10","author":"S Torres","year":"2011","unstructured":"Torres, S. et al. A combined preclinical therapy of cannabinoids and temozolomide against glioma. Mol. Cancer Ther. 10, 90\u2013103 (2011).","journal-title":"Mol. Cancer Ther."},{"key":"864_CR41","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/sj.bjc.6604969","volume":"100","author":"IV Ulasov","year":"2009","unstructured":"Ulasov, I. V. et al. Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo. Br. J. Cancer 100, 1154\u20131164 (2009).","journal-title":"Br. J. Cancer"},{"key":"864_CR42","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1158\/0008-5472.CAN-07-5575","volume":"69","author":"IF Robey","year":"2009","unstructured":"Robey, I. F. et al. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res. 69, 2260\u20132268 (2009).","journal-title":"Cancer Res."},{"key":"864_CR43","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1002\/ijc.30646","volume":"140","author":"J P\u00f6tzl","year":"2017","unstructured":"P\u00f6tzl, J. et al. Reversal of tumor acidosis by systemic buffering reactivates NK cells to express IFN-\u03b3 and induces NK cell-dependent lymphoma control without other immunotherapies. Int. J. Cancer 140, 2125\u20132133 (2017).","journal-title":"Int. J. Cancer"},{"key":"864_CR44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.semcdb.2014.07.002","volume":"35","author":"S Fulda","year":"2014","unstructured":"Fulda, S. Therapeutic exploitation of necroptosis for cancer therapy. Semin. Cell. Dev. Biol. 35, 51\u201356 (2014).","journal-title":"Semin. Cell. Dev. Biol."},{"key":"864_CR45","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.cell.2008.10.044","volume":"7","author":"J Hitomi.","year":"2008","unstructured":"Hitomi., J. et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 7, 1311\u20131323 (2008).","journal-title":"Cell"},{"key":"864_CR46","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1158\/1535-7163.MCT-06-0511","volume":"6","author":"W Han","year":"2007","unstructured":"Han, W. et al. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol. Cancer Ther. 6, 1641\u20131649 (2007).","journal-title":"Mol. Cancer Ther."},{"key":"864_CR47","doi-asserted-by":"publisher","first-page":"72882","DOI":"10.1371\/journal.pone.0072882","volume":"8","author":"IO Racoma","year":"2013","unstructured":"Racoma, I. O., Meisen, W. H., Wang, Q. E., Kaur, B. & Wani, A. A. Thymoquinone inhibits autophagy and induces cathepsin-mediated, caspase-independent cell death in glioblastoma cells. PLoS One 8, 72882 (2013).","journal-title":"PLoS One"},{"key":"864_CR48","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","volume":"73","author":"JY Cao","year":"2016","unstructured":"Cao, J. Y. & Dixon, S. J. Mechanisms of ferroptosis. Cell. Mol. Life Sci. 73, 2195\u20132209 (2016).","journal-title":"Cell. Mol. Life Sci."},{"key":"864_CR49","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/imr.12533","volume":"277","author":"SJ Dixon","year":"2017","unstructured":"Dixon, S. J. Ferroptosis: bug or feature? Immunol 277, 150\u2013157 (2017).","journal-title":"Immunol"},{"key":"864_CR50","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"5","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of non-apoptotic cell death. Cell 5, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"864_CR51","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie, Y. et al. Ferroptosis: process and function. Cell Death Differ. 23, 369\u2013379 (2016).","journal-title":"Cell Death Differ."},{"key":"864_CR52","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli, J. P. et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16, 1180\u20131191 (2014).","journal-title":"Nat. Cell Biol."},{"key":"864_CR53","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1021\/acscentsci.6b00199","volume":"9","author":"T Krainz","year":"2016","unstructured":"Krainz, T. et al. A mitochondrial-targeted nitroxide is a potent inhibitor of ferroptosis. ACS Cent. Sci. 9, 653\u2013659 (2016).","journal-title":"ACS Cent. Sci."},{"key":"864_CR54","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang, W. S. et al. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc. Natl. Acad. Sci. Usa. 113, E4966\u2013E4975 (2016).","journal-title":"Proc. Natl. Acad. Sci. Usa."},{"key":"864_CR55","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3892\/or.2015.3712","volume":"33","author":"L Chen","year":"2015","unstructured":"Chen, L. et al. Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine\u2010gamma\u2010lyase function. Oncol. Rep. 33, 1465\u20131474 (2015).","journal-title":"Oncol. Rep."},{"key":"864_CR56","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/nchem.2778","volume":"9","author":"TT Mai","year":"2017","unstructured":"Mai, T. T. et al. Salinomycin kills cancer stem cells by sequestering iron in lysosomes. Nat. Chem. 9, 1025\u20131033 (2017).","journal-title":"Nat. Chem."},{"key":"864_CR57","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1080\/15548627.2017.1327104","volume":"13","author":"A Hama\u00ef","year":"2017","unstructured":"Hama\u00ef, A. et al. An iron hand over cancer stem cells. Autophagy 13, 1465\u20131466 (2017).","journal-title":"Autophagy"},{"key":"864_CR58","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1042\/BJ20150658","volume":"473","author":"S Torii","year":"2016","unstructured":"Torii, S. et al. An essential role for functional lysosomes in ferroptosis of cancer cells. Biochem. J. 473, 769\u2013777 (2016).","journal-title":"Biochem. J."},{"key":"864_CR59","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","volume":"12","author":"W Hou","year":"2016","unstructured":"Hou, W. et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy 12, 1425\u20131428 (2016).","journal-title":"Autophagy"},{"key":"864_CR60","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/cr.2016.95","volume":"26","author":"M Gao","year":"2016","unstructured":"Gao, M. et al. Ferroptosis is an autophagic cell death process. Cell Res. 26, 1021\u20131032 (2016).","journal-title":"Cell Res."},{"key":"864_CR61","first-page":"3750","volume":"13","author":"P Casalbore","year":"2003","unstructured":"Casalbore, P., Maggiano, N., Levi, A., Larocca, L. M. & Pallini, R. Glioblastoma induces vascular endothelial cells to express telomerase in vitro. Cancer Res. 13, 3750\u201337544 (2003).","journal-title":"Cancer Res."},{"key":"864_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.188","volume":"5","author":"M Signore","year":"2014","unstructured":"Signore, M. et al. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo. Cell Death Dis. 5, e1223 (2014).","journal-title":"Cell Death Dis."},{"key":"864_CR63","doi-asserted-by":"publisher","first-page":"8462","DOI":"10.1128\/JVI.77.15.8462-8469.2003","volume":"77","author":"A Barret","year":"2003","unstructured":"Barret, A. et al. Evaluation of quinacrine treatment for prion diseases. J. Virol. 77, 8462\u20138469 (2003).","journal-title":"J. Virol."},{"key":"864_CR64","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(01)05748-8","volume":"358","author":"R Love","year":"2001","unstructured":"Love, R. Old drugs to treat new variant Creutzfeldt-Jakob disease. Lancet 358, 563 (2001).","journal-title":"Lancet"},{"key":"864_CR65","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/cdd.2012.44","volume":"19","author":"CM Tate","year":"2012","unstructured":"Tate, C. M. et al. A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells. Cell Death Diff. 19, 1644\u20131654 (2012).","journal-title":"Cell Death Diff."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0864-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0864-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0864-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:02:47Z","timestamp":1671537767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0864-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":65,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8]]}},"alternative-id":["864"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0864-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]},"assertion":[{"value":"3 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"841"}}